copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Charles River Laboratories | Because every moment matters Charles River provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics Transform Possibilities Into Breakthroughs Because every moment matters
Our Story - Charles River Laboratories What once started as a one-man laboratory in Boston in 1947, overlooking the Charles River, has evolved into a leading global strategic partner providing products and services to help expedite the discovery, early-stage development, and safe manufacture of novel drugs and therapeutics
Products Services | Charles River - Charles River Laboratories By continuing to grow in response to our clients' needs, we can now offer the most comprehensive, integrated portfolio of drug development products and services available from a single global provider, spanning the continuum from early research to the support of marketed products
Locations - Charles River Laboratories In addition, Charles River utilizes distributors and sales agents to represent our various products and services in certain geographies as well as upholds relationships with several collaborators that provide supplementary offerings For more information, click the appropriate service area below: Research Animal Models and Services
Charles River Laboratories Announces First-Quarter 2025 Results . . . WILMINGTON, Mass --(BUSINESS WIRE)--May 7, 2025-- Charles River Laboratories International, Inc (NYSE: CRL) today reported its results for the first quarter of 2025 For the quarter, revenue was $984 2 million , a decrease of 2 7% from $1,011 6 million in the first quarter of 2024
Charles River Laboratories Announces Governance Updates and Strategic . . . Charles River’s Board of Directors has agreed to appoint four new directors, Steven Barg, Abe Ceesay, Mark Enyedy, and Paul Graves, who will join the Board effective following the 2025 Annual Meeting of Shareholders to be held on May 20, 2025
Charles River Leverages Advanced Technology to Expedite Oncology Drug . . . Charles River offers a comprehensive line of humanized mice models to support researchers in replicating human immune interactions and therapeutics responses in controlled, in vivo environments Charles River has expanded its offering of humanized mouse models by introducing two new PBMC models that reduce the onset of graft versus host disease